These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 9365241

  • 1. Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine.
    Huang Y, Yuan ZM, Ishiko T, Nakada S, Utsugisawa T, Kato T, Kharbanda S, Kufe DW.
    Oncogene; 1997 Oct 16; 15(16):1947-52. PubMed ID: 9365241
    [Abstract] [Full Text] [Related]

  • 2. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 16; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 3. Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53.
    Yuan ZM, Huang Y, Fan MM, Sawyers C, Kharbanda S, Kufe D.
    J Biol Chem; 1996 Oct 25; 271(43):26457-60. PubMed ID: 8900110
    [Abstract] [Full Text] [Related]

  • 4. The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase.
    Chapman RS, Whetton AD, Dive C.
    Cancer Res; 1994 Oct 01; 54(19):5131-7. PubMed ID: 7923130
    [Abstract] [Full Text] [Related]

  • 5. Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.
    Yoshida K.
    Trends Mol Med; 2008 Jul 01; 14(7):305-13. PubMed ID: 18539531
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage.
    Nehmé A, Lee BL, Baskaran R, Zhang Q, Lin X, Christen RD.
    Br J Cancer; 2000 Nov 01; 83(10):1360-6. PubMed ID: 11044362
    [Abstract] [Full Text] [Related]

  • 8. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.
    Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y.
    Nat Cell Biol; 2005 Mar 01; 7(3):278-85. PubMed ID: 15696159
    [Abstract] [Full Text] [Related]

  • 9. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 10. Proliferating cell nuclear antigen destabilizes c-Abl tyrosine kinase and regulates cell apoptosis in response to DNA damage.
    He X, Wei C, Song T, Yuan J, Zhang Y, Ma Q, Shi W, Zhong H.
    Apoptosis; 2009 Mar 15; 14(3):268-75. PubMed ID: 19156526
    [Abstract] [Full Text] [Related]

  • 11. RB-resistant Abl kinase induces delayed cell cycle progression and increases susceptibility to apoptosis upon cellular stresses through interaction with p53.
    Cho JW, Chung J, Baek WK, Suh SI, Kwon TK, Park JW, Suh MH.
    Int J Oncol; 2003 Jun 15; 22(6):1193-9. PubMed ID: 12738983
    [Abstract] [Full Text] [Related]

  • 12. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.
    Mc Gee MM, Campiani G, Ramunno A, Fattorusso C, Nacci V, Lawler M, Williams DC, Zisterer DM.
    J Pharmacol Exp Ther; 2001 Jan 15; 296(1):31-40. PubMed ID: 11123359
    [Abstract] [Full Text] [Related]

  • 13. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells.
    Dou QP, McGuire TF, Peng Y, An B.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):781-90. PubMed ID: 10215653
    [Abstract] [Full Text] [Related]

  • 14. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.
    Kurosu T, Tsuji K, Kida A, Koyama T, Yamamoto M, Miura O.
    Oncogene; 2007 May 10; 26(21):2975-87. PubMed ID: 17130834
    [Abstract] [Full Text] [Related]

  • 15. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.
    Kobayashi T, Ruan S, Jabbur JR, Consoli U, Clodi K, Shiku H, Owen-Schaub LB, Andreeff M, Reed JC, Zhang W.
    Cell Death Differ; 1998 Jul 10; 5(7):584-91. PubMed ID: 10200513
    [Abstract] [Full Text] [Related]

  • 16. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
    Stiewe T, Parssanedjad K, Esche H, Opalka B, Pützer BM.
    Cancer Res; 2000 Jul 15; 60(14):3957-64. PubMed ID: 10919674
    [Abstract] [Full Text] [Related]

  • 17. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW, Huang HC.
    Br J Pharmacol; 1998 Jul 15; 124(6):1029-40. PubMed ID: 9720770
    [Abstract] [Full Text] [Related]

  • 18. Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells.
    Dan S, Naito M, Seimiya H, Kizaki A, Mashima T, Tsuruo T.
    Oncogene; 1999 Feb 11; 18(6):1277-83. PubMed ID: 10022809
    [Abstract] [Full Text] [Related]

  • 19. PKCdelta signaling: mechanisms of DNA damage response and apoptosis.
    Yoshida K.
    Cell Signal; 2007 May 11; 19(5):892-901. PubMed ID: 17336499
    [Abstract] [Full Text] [Related]

  • 20. Role of c-Abl in the DNA damage stress response.
    Shaul Y, Ben-Yehoyada M.
    Cell Res; 2005 Jan 11; 15(1):33-5. PubMed ID: 15686624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.